{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:02:50Z","timestamp":1791277370300,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/gme.0b013e3182775fe9","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T03:40:55Z","timestamp":1356147655000},"page":"47-56","source":"Crossref","is-referenced-by-count":13,"title":["Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause"],"prefix":"10.1097","volume":"20","author":[{"given":"David F.","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn V.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Guico-Pabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-fong J.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210211","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2005-869479","article-title":"Pathophysiology and treatment of menopausal hot flashes.","volume":"23","author":"Freedman","year":"2005","journal-title":"Semin Reprod Med"},{"key":"R2-9-20210211","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5122(00)00151-1","article-title":"The role of serotonin in hot flushes.","volume":"36","author":"Berendsen","year":"2000","journal-title":"Maturitas"},{"key":"R3-9-20210211","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00737-007-0209-5","article-title":"Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.","volume":"10","author":"Deecher","year":"2007","journal-title":"Arch Womens Ment Health"},{"key":"R4-9-20210211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R5-9-20210211","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"R6-9-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjmed.2007.10.007","article-title":"Paroxetine versus placebo for women in midlife after hormone therapy discontinuation.","volume":"121","author":"Soares","year":"2008","journal-title":"Am J Med"},{"key":"R7-9-20210211","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.gme.0000196595.82452.ca","article-title":"Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population.","volume":"13","author":"Gordon","year":"2006","journal-title":"Menopause"},{"key":"R8-9-20210211","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2009.26.6379","article-title":"Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.","volume":"28","author":"Barton","year":"2010","journal-title":"J Clin Oncol"},{"key":"R9-9-20210211","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.2010.2016","article-title":"Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.","volume":"305","author":"Freeman","year":"2011","journal-title":"JAMA"},{"key":"R13-9-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000297371.89129.b3","article-title":"Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.","volume":"111","author":"Speroff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R14-9-20210211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/13697137.2011.586445","article-title":"Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.","volume":"15","author":"Bouchard","year":"2012","journal-title":"Climacteric"},{"key":"R15-9-20210211","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/gme.0b013e31826421a8","article-title":"Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.","volume":"20","author":"Pinkerton","year":"2012","journal-title":"Menopause"},{"key":"R16-9-20210211","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/gme.0b013e318274699f","article-title":"Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial.","volume":"20","author":"Pinkerton","year":"2012","journal-title":"Menopause"},{"key":"R17-9-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5122(98)00025-5","article-title":"Constructing a standard climacteric scale.","volume":"29","author":"Greene","year":"1998","journal-title":"Maturitas"},{"key":"R18-9-20210211","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction.","volume":"50","author":"Thygesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R19-9-20210211","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1092852900020204","article-title":"An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.","volume":"14","author":"Clayton","year":"2009","journal-title":"CNS Spectr"},{"key":"R20-9-20210211","first-page":"574","article-title":"Cardiovascular safety in depressed patients: focus on venlafaxine.","volume":"56","author":"Feighner","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"R21-9-20210211","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/070674370605101408","article-title":"Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.","volume":"51","author":"Swenson","year":"2006","journal-title":"Can J Psychiatry"},{"key":"R22-9-20210211","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000079172.43229.CD","article-title":"Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.","volume":"108","author":"Sauer","year":"2003","journal-title":"Circulation"},{"key":"R23-9-20210211","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/eurheartj\/ehq438","article-title":"Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.","volume":"32","author":"Hamer","year":"2011","journal-title":"Eur Heart J"},{"key":"R24-9-20210211","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1001\/archinternmed.2009.436","article-title":"Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Womens Health Initiative study.","volume":"169","author":"Smoller","year":"2009","journal-title":"Arch Intern Med"},{"key":"R25-9-20210211","first-page":"305","article-title":"Cardiovascular side effects of newer antidepressants.","volume":"7","author":"Fernandez","year":"2007","journal-title":"Anadolu Kardiyol Derg"},{"key":"R26-9-20210211","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","article-title":"An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.","volume":"30","author":"Wernicke","year":"2007","journal-title":"Drug Saf"},{"key":"R28-9-20210211","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1092852900020204","article-title":"An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.","volume":"14","author":"Clayton","year":"2009","journal-title":"CNS Spectr"},{"key":"R30-9-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R31-9-20210211","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/gme.0b013e3182775fe9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:36:32Z","timestamp":1620977792000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201301000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3182775fe9","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}